Highlights from LSI USA '24 Emerging Medtech Summit

Bart Schade
May 8, 2024
1 min read

Watch this insightful presentation by CEO Steven Mickelsen where he shared perspectives on current market trends in ventricular arrhythmia ablation and Field Medical's mission to bring transformative treatments for VT patients.

Recent Posts

See All

Field Medical's FieldForce™ Ablation System Earns FDA TAP Pilot Acceptance and Breakthrough Device Designation for the Treatment of Ventricular Tachycardia.

LSI Europe '24 Presentation

Field Medical Announces First-in-Human Trials for Groundbreaking FieldForce™ Ventricular Pulsed Field Ablation Technology